Theralase Technologies Stock Market Value
| TLT Stock | CAD 0.28 0.01 3.70% |
| Symbol | Theralase |
Theralase Technologies Price To Book Ratio
Theralase Technologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Theralase Technologies' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Theralase Technologies.
| 01/02/2025 |
| 02/01/2025 |
If you would invest 0.00 in Theralase Technologies on January 2, 2025 and sell it all today you would earn a total of 0.00 from holding Theralase Technologies or generate 0.0% return on investment in Theralase Technologies over 30 days. Theralase Technologies is related to or competes with Theralase Technologies, Reliq Health, and Microbix Biosystems. Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo d... More
Theralase Technologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Theralase Technologies' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Theralase Technologies upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 8.95 | |||
| Information Ratio | 0.0383 | |||
| Maximum Drawdown | 37.69 | |||
| Value At Risk | (7.41) | |||
| Potential Upside | 8.0 |
Theralase Technologies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Theralase Technologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Theralase Technologies' standard deviation. In reality, there are many statistical measures that can use Theralase Technologies historical prices to predict the future Theralase Technologies' volatility.| Risk Adjusted Performance | 0.0515 | |||
| Jensen Alpha | 0.2874 | |||
| Total Risk Alpha | (0.20) | |||
| Sortino Ratio | 0.0262 | |||
| Treynor Ratio | 1.35 |
Theralase Technologies Backtested Returns
Theralase Technologies appears to be out of control, given 3 months investment horizon. Theralase Technologies owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0523, which indicates the firm had a 0.0523 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Theralase Technologies, which you can use to evaluate the volatility of the company. Please review Theralase Technologies' Risk Adjusted Performance of 0.0515, semi deviation of 5.97, and Coefficient Of Variation of 1955.8 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Theralase Technologies holds a performance score of 4. The entity has a beta of 0.22, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Theralase Technologies' returns are expected to increase less than the market. However, during the bear market, the loss of holding Theralase Technologies is expected to be smaller as well. Please check Theralase Technologies' total risk alpha and the relationship between the potential upside and day typical price , to make a quick decision on whether Theralase Technologies' existing price patterns will revert.
Auto-correlation | -0.63 |
Very good reverse predictability
Theralase Technologies has very good reverse predictability. Overlapping area represents the amount of predictability between Theralase Technologies time series from 2nd of January 2025 to 17th of January 2025 and 17th of January 2025 to 1st of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Theralase Technologies price movement. The serial correlation of -0.63 indicates that roughly 63.0% of current Theralase Technologies price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.63 | |
| Spearman Rank Test | -0.18 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Theralase Technologies lagged returns against current returns
Autocorrelation, which is Theralase Technologies stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Theralase Technologies' stock expected returns. We can calculate the autocorrelation of Theralase Technologies returns to help us make a trade decision. For example, suppose you find that Theralase Technologies has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Theralase Technologies regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Theralase Technologies stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Theralase Technologies stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Theralase Technologies stock over time.
Current vs Lagged Prices |
| Timeline |
Theralase Technologies Lagged Returns
When evaluating Theralase Technologies' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Theralase Technologies stock have on its future price. Theralase Technologies autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Theralase Technologies autocorrelation shows the relationship between Theralase Technologies stock current value and its past values and can show if there is a momentum factor associated with investing in Theralase Technologies.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Theralase Stock Analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.